Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mecp2
|
ENSMUSG00000031393.10 | methyl CpG binding protein 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_74085133_74085473 | Mecp2 | 294 | 0.847212 | 0.86 | 2.8e-02 | Click! |
chrX_74084950_74085119 | Mecp2 | 563 | 0.651490 | 0.44 | 3.8e-01 | Click! |
chrX_74085732_74085900 | Mecp2 | 126 | 0.939355 | 0.07 | 8.9e-01 | Click! |
chrX_74084763_74084914 | Mecp2 | 759 | 0.527718 | 0.05 | 9.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_46133855_46134398 | 3.14 |
Elovl3 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
2229 |
0.19 |
chr5_122284523_122284674 | 3.11 |
Pptc7 |
PTC7 protein phosphatase homolog |
233 |
0.88 |
chr15_100636821_100637012 | 2.78 |
Smagp |
small cell adhesion glycoprotein |
24 |
0.94 |
chr4_133753668_133753824 | 2.62 |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
135 |
0.95 |
chr2_19658586_19658737 | 2.47 |
Otud1 |
OTU domain containing 1 |
909 |
0.47 |
chr8_120487540_120487709 | 2.46 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
823 |
0.56 |
chr3_83033017_83033348 | 2.17 |
Fga |
fibrinogen alpha chain |
6967 |
0.14 |
chr1_39194066_39194239 | 2.15 |
Npas2 |
neuronal PAS domain protein 2 |
60 |
0.97 |
chr18_65935212_65935366 | 2.11 |
Raxos1 |
retina and anterior neural fold homeobox, opposite strand 1 |
2249 |
0.15 |
chr5_52975538_52975768 | 2.09 |
Gm30301 |
predicted gene, 30301 |
6384 |
0.16 |
chr8_122678212_122678419 | 2.05 |
Cbfa2t3 |
CBFA2/RUNX1 translocation partner 3 |
140 |
0.92 |
chr19_12501275_12501426 | 1.97 |
Dtx4 |
deltex 4, E3 ubiquitin ligase |
104 |
0.94 |
chr7_65370516_65370694 | 1.96 |
Tjp1 |
tight junction protein 1 |
410 |
0.84 |
chr2_153528144_153528295 | 1.95 |
Nol4l |
nucleolar protein 4-like |
1752 |
0.37 |
chr5_93267759_93267991 | 1.91 |
Ccng2 |
cyclin G2 |
236 |
0.93 |
chrX_140540868_140541026 | 1.88 |
Tsc22d3 |
TSC22 domain family, member 3 |
1721 |
0.38 |
chr6_134792808_134792986 | 1.80 |
Dusp16 |
dual specificity phosphatase 16 |
272 |
0.89 |
chr5_93044127_93044467 | 1.79 |
Sowahb |
sosondowah ankyrin repeat domain family member B |
725 |
0.57 |
chr2_52858397_52858587 | 1.77 |
Fmnl2 |
formin-like 2 |
624 |
0.82 |
chr6_72630800_72631102 | 1.76 |
Tcf7l1 |
transcription factor 7 like 1 (T cell specific, HMG box) |
681 |
0.4 |
chr6_29735921_29736084 | 1.73 |
Smo |
smoothened, frizzled class receptor |
308 |
0.87 |
chr11_5057951_5058115 | 1.72 |
Rasl10a |
RAS-like, family 10, member A |
95 |
0.94 |
chr11_102296039_102296190 | 1.70 |
Atxn7l3 |
ataxin 7-like 3 |
515 |
0.63 |
chr15_100747270_100747466 | 1.70 |
Slc4a8 |
solute carrier family 4 (anion exchanger), member 8 |
14379 |
0.11 |
chr3_57847046_57847210 | 1.68 |
Pfn2 |
profilin 2 |
17 |
0.97 |
chr15_89089216_89089375 | 1.67 |
Selenoo |
selenoprotein O |
211 |
0.86 |
chr12_99563615_99563963 | 1.66 |
Gm26839 |
predicted gene, 26839 |
7 |
0.73 |
chr11_75194251_75194940 | 1.66 |
Rtn4rl1 |
reticulon 4 receptor-like 1 |
812 |
0.43 |
chr15_102186991_102187189 | 1.63 |
Csad |
cysteine sulfinic acid decarboxylase |
509 |
0.65 |
chr3_139205535_139205701 | 1.63 |
Stpg2 |
sperm tail PG rich repeat containing 2 |
76 |
0.98 |
chr4_119539797_119539948 | 1.62 |
Foxj3 |
forkhead box J3 |
93 |
0.77 |
chr16_38902364_38902543 | 1.62 |
Igsf11 |
immunoglobulin superfamily, member 11 |
55 |
0.98 |
chr12_83951067_83951218 | 1.60 |
Gm26571 |
predicted gene, 26571 |
213 |
0.74 |
chr3_129533746_129533917 | 1.60 |
Elovl6 |
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
1104 |
0.37 |
chr8_85700892_85701043 | 1.59 |
Neto2 |
neuropilin (NRP) and tolloid (TLL)-like 2 |
43 |
0.51 |
chr19_46137089_46137240 | 1.56 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
125 |
0.94 |
chr6_120037558_120037709 | 1.54 |
Wnk1 |
WNK lysine deficient protein kinase 1 |
26 |
0.97 |
chr11_86993297_86993457 | 1.53 |
Ypel2 |
yippee like 2 |
330 |
0.86 |
chr1_39192284_39192607 | 1.52 |
Npas2 |
neuronal PAS domain protein 2 |
1286 |
0.45 |
chr9_21239006_21239167 | 1.52 |
Keap1 |
kelch-like ECH-associated protein 1 |
7 |
0.95 |
chr6_72512803_72513005 | 1.51 |
Sh2d6 |
SH2 domain containing 6 |
7111 |
0.14 |
chr17_80480163_80480314 | 1.50 |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
215 |
0.95 |
chr10_52690737_52690888 | 1.49 |
Slc35f1 |
solute carrier family 35, member F1 |
279 |
0.9 |
chr17_50509012_50509163 | 1.49 |
Plcl2 |
phospholipase C-like 2 |
316 |
0.94 |
chr6_125494372_125494563 | 1.49 |
Gm26728 |
predicted gene, 26728 |
37 |
0.82 |
chr9_67633329_67633668 | 1.49 |
Gm47110 |
predicted gene, 47110 |
66683 |
0.09 |
chr11_98022495_98022646 | 1.48 |
Cacnb1 |
calcium channel, voltage-dependent, beta 1 subunit |
57 |
0.82 |
chrX_95444258_95444723 | 1.48 |
Amer1 |
APC membrane recruitment 1 |
382 |
0.88 |
chr11_103101789_103101949 | 1.47 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
143 |
0.59 |
chr9_37146676_37146845 | 1.47 |
Pknox2 |
Pbx/knotted 1 homeobox 2 |
506 |
0.7 |
chr3_96527165_96527465 | 1.47 |
Hjv |
hemojuvelin BMP co-receptor |
2143 |
0.13 |
chr19_3691348_3691719 | 1.47 |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
4969 |
0.12 |
chr8_94666713_94666864 | 1.45 |
Arl2bp |
ADP-ribosylation factor-like 2 binding protein |
64 |
0.95 |
chr3_52103956_52104113 | 1.45 |
Maml3 |
mastermind like transcriptional coactivator 3 |
1042 |
0.46 |
chr15_96699087_96699266 | 1.45 |
Slc38a2 |
solute carrier family 38, member 2 |
485 |
0.66 |
chr7_35215228_35215399 | 1.44 |
Lrp3 |
low density lipoprotein receptor-related protein 3 |
21 |
0.96 |
chr11_86993037_86993196 | 1.43 |
Ypel2 |
yippee like 2 |
591 |
0.7 |
chr9_65827463_65827636 | 1.43 |
Zfp609 |
zinc finger protein 609 |
15 |
0.97 |
chr11_117266979_117267153 | 1.43 |
Septin9 |
septin 9 |
820 |
0.6 |
chr2_164563632_164563783 | 1.42 |
Wfdc2 |
WAP four-disulfide core domain 2 |
688 |
0.45 |
chr19_42612808_42613017 | 1.42 |
Loxl4 |
lysyl oxidase-like 4 |
99 |
0.97 |
chr8_11557092_11557270 | 1.41 |
Ing1 |
inhibitor of growth family, member 1 |
1015 |
0.43 |
chr9_119146566_119146717 | 1.40 |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
3422 |
0.14 |
chr12_70111679_70111850 | 1.40 |
Nin |
ninein |
135 |
0.94 |
chr19_46135842_46135993 | 1.40 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
1372 |
0.29 |
chr6_116193076_116193281 | 1.39 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
308 |
0.82 |
chr2_155236688_155236852 | 1.39 |
Dynlrb1 |
dynein light chain roadblock-type 1 |
41 |
0.97 |
chr1_168476281_168476457 | 1.38 |
Mir6348 |
microRNA 6348 |
14274 |
0.25 |
chr1_136345470_136345747 | 1.38 |
Camsap2 |
calmodulin regulated spectrin-associated protein family, member 2 |
90 |
0.97 |
chr5_140648568_140648783 | 1.37 |
Ttyh3 |
tweety family member 3 |
322 |
0.85 |
chr13_97241300_97241504 | 1.36 |
Enc1 |
ectodermal-neural cortex 1 |
297 |
0.89 |
chr2_83724667_83724818 | 1.36 |
Itgav |
integrin alpha V |
187 |
0.93 |
chr3_94398218_94398392 | 1.35 |
Lingo4 |
leucine rich repeat and Ig domain containing 4 |
212 |
0.81 |
chr10_122047339_122047490 | 1.35 |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
99 |
0.96 |
chr2_160366758_160366909 | 1.35 |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
232 |
0.95 |
chr1_181475618_181475786 | 1.34 |
Ccdc121 |
coiled-coil domain containing 121 |
35749 |
0.14 |
chr18_60501017_60501168 | 1.34 |
Smim3 |
small integral membrane protein 3 |
484 |
0.78 |
chr4_43656130_43656321 | 1.34 |
Hint2 |
histidine triad nucleotide binding protein 2 |
218 |
0.81 |
chr7_3289204_3289795 | 1.33 |
Prkcg |
protein kinase C, gamma |
320 |
0.51 |
chr1_40681307_40681458 | 1.33 |
Slc9a2 |
solute carrier family 9 (sodium/hydrogen exchanger), member 2 |
215 |
0.93 |
chr7_67950974_67951162 | 1.32 |
Igf1r |
insulin-like growth factor I receptor |
1759 |
0.41 |
chr12_21144959_21145110 | 1.31 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
33080 |
0.16 |
chr4_148149701_148149870 | 1.30 |
Fbxo6 |
F-box protein 6 |
66 |
0.94 |
chr8_13200514_13200674 | 1.29 |
Grtp1 |
GH regulated TBC protein 1 |
7 |
0.61 |
chr16_22698076_22698372 | 1.29 |
Gm8118 |
predicted gene 8118 |
12030 |
0.18 |
chr13_93621560_93621754 | 1.28 |
Gm15622 |
predicted gene 15622 |
3725 |
0.2 |
chr12_21167940_21168115 | 1.28 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
56073 |
0.1 |
chr17_32492940_32493118 | 1.28 |
Cyp4f39 |
cytochrome P450, family 4, subfamily f, polypeptide 39 |
871 |
0.5 |
chr15_51991239_51991390 | 1.28 |
Rad21 |
RAD21 cohesin complex component |
196 |
0.94 |
chr14_57100725_57100905 | 1.28 |
Gjb2 |
gap junction protein, beta 2 |
3887 |
0.18 |
chr5_145863518_145863716 | 1.26 |
Cyp3a11 |
cytochrome P450, family 3, subfamily a, polypeptide 11 |
13074 |
0.16 |
chr19_37435429_37435580 | 1.26 |
Hhex |
hematopoietically expressed homeobox |
694 |
0.42 |
chr3_86002499_86002650 | 1.26 |
Prss48 |
protease, serine 48 |
83 |
0.96 |
chr12_26469593_26469793 | 1.26 |
Cmpk2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
489 |
0.75 |
chr17_74294529_74294759 | 1.26 |
Memo1 |
mediator of cell motility 1 |
146 |
0.94 |
chr9_44319923_44320178 | 1.25 |
C2cd2l |
C2 calcium-dependent domain containing 2-like |
202 |
0.81 |
chr1_57775069_57775220 | 1.25 |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
227 |
0.96 |
chr5_114560586_114560754 | 1.24 |
Fam222a |
family with sequence similarity 222, member A |
7346 |
0.16 |
chr14_34549199_34549382 | 1.24 |
9230112D13Rik |
RIKEN cDNA 9230112D13 gene |
26489 |
0.1 |
chr6_94283507_94283677 | 1.24 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
270 |
0.93 |
chr12_28898892_28899474 | 1.23 |
Gm31508 |
predicted gene, 31508 |
11046 |
0.17 |
chr6_29215944_29216165 | 1.23 |
Impdh1 |
inosine monophosphate dehydrogenase 1 |
125 |
0.94 |
chr13_9094385_9094550 | 1.23 |
Larp4b |
La ribonucleoprotein domain family, member 4B |
485 |
0.77 |
chr2_181212825_181213064 | 1.23 |
Srms |
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites |
241 |
0.83 |
chr11_52282949_52283100 | 1.22 |
Tcf7 |
transcription factor 7, T cell specific |
307 |
0.86 |
chr8_34965417_34965568 | 1.22 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
198 |
0.72 |
chr11_63921851_63922025 | 1.22 |
Hs3st3b1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
352 |
0.9 |
chr17_29093649_29093812 | 1.20 |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
39 |
0.91 |
chr10_84811999_84812153 | 1.20 |
Gm24226 |
predicted gene, 24226 |
893 |
0.64 |
chr3_127837149_127837304 | 1.19 |
Ap1ar |
adaptor-related protein complex 1 associated regulatory protein |
5 |
0.81 |
chr2_173659976_173660127 | 1.19 |
Rab22a |
RAB22A, member RAS oncogene family |
195 |
0.72 |
chr6_50175016_50175173 | 1.19 |
Mpp6 |
membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) |
5206 |
0.25 |
chr5_77357793_77357964 | 1.19 |
Polr2b |
polymerase (RNA) II (DNA directed) polypeptide B |
17510 |
0.13 |
chr7_44816552_44816741 | 1.18 |
Atf5 |
activating transcription factor 5 |
12 |
0.63 |
chr9_48860359_48860556 | 1.18 |
Zbtb16 |
zinc finger and BTB domain containing 16 |
24235 |
0.17 |
chr16_23995561_23995930 | 1.18 |
Bcl6 |
B cell leukemia/lymphoma 6 |
6893 |
0.17 |
chr3_130059712_130060230 | 1.18 |
Sec24b |
Sec24 related gene family, member B (S. cerevisiae) |
936 |
0.52 |
chr5_135888537_135888702 | 1.18 |
Hspb1 |
heat shock protein 1 |
601 |
0.58 |
chr19_47068097_47068282 | 1.17 |
Taf5 |
TATA-box binding protein associated factor 5 |
443 |
0.69 |
chr10_108333096_108333283 | 1.17 |
Pawr |
PRKC, apoptosis, WT1, regulator |
372 |
0.88 |
chr17_12405476_12405627 | 1.17 |
Plg |
plasminogen |
26892 |
0.14 |
chr14_54434127_54434453 | 1.17 |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
1854 |
0.16 |
chr18_32163233_32163401 | 1.16 |
Map3k2 |
mitogen-activated protein kinase kinase kinase 2 |
121 |
0.94 |
chr19_4712306_4712457 | 1.16 |
Sptbn2 |
spectrin beta, non-erythrocytic 2 |
3 |
0.96 |
chr11_97440001_97440191 | 1.16 |
Arhgap23 |
Rho GTPase activating protein 23 |
3811 |
0.2 |
chr3_116329378_116329892 | 1.16 |
Gm29151 |
predicted gene 29151 |
20468 |
0.17 |
chr8_124231862_124232030 | 1.15 |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
438 |
0.84 |
chr16_81200321_81200657 | 1.15 |
Ncam2 |
neural cell adhesion molecule 2 |
208 |
0.96 |
chr2_93462882_93463070 | 1.14 |
Cd82 |
CD82 antigen |
30 |
0.97 |
chr9_43544933_43545084 | 1.14 |
Gm36855 |
predicted gene, 36855 |
24004 |
0.17 |
chr10_75932476_75932648 | 1.14 |
Mmp11 |
matrix metallopeptidase 11 |
60 |
0.87 |
chr8_36187409_36187597 | 1.14 |
Gm35520 |
predicted gene, 35520 |
869 |
0.53 |
chr7_24237638_24237797 | 1.13 |
Zfp109 |
zinc finger protein 109 |
157 |
0.9 |
chr8_25840480_25840643 | 1.13 |
Ash2l |
ASH2 like histone lysine methyltransferase complex subunit |
104 |
0.95 |
chr11_75291668_75291835 | 1.13 |
Gm47300 |
predicted gene, 47300 |
26857 |
0.12 |
chr2_6068771_6068945 | 1.13 |
Upf2 |
UPF2 regulator of nonsense transcripts homolog (yeast) |
18431 |
0.18 |
chr8_95807155_95807326 | 1.13 |
Cnot1 |
CCR4-NOT transcription complex, subunit 1 |
141 |
0.65 |
chr10_31609265_31609554 | 1.12 |
Rnf217 |
ring finger protein 217 |
225 |
0.93 |
chr2_154585868_154586214 | 1.12 |
E2f1 |
E2F transcription factor 1 |
16149 |
0.09 |
chr17_30659259_30659436 | 1.12 |
Dnah8 |
dynein, axonemal, heavy chain 8 |
4011 |
0.17 |
chr17_28350412_28350637 | 1.12 |
Tead3 |
TEA domain family member 3 |
76 |
0.94 |
chr8_120668006_120668174 | 1.12 |
Emc8 |
ER membrane protein complex subunit 8 |
3 |
0.38 |
chr12_28905624_28905792 | 1.12 |
Gm31508 |
predicted gene, 31508 |
4521 |
0.21 |
chr6_88445522_88446347 | 1.12 |
Gm44264 |
predicted gene, 44264 |
247 |
0.73 |
chr7_127615002_127615170 | 1.12 |
Zfp629 |
zinc finger protein 629 |
114 |
0.91 |
chr19_36627452_36627789 | 1.12 |
Hectd2os |
Hectd2, opposite strand |
1596 |
0.43 |
chr15_39006411_39006597 | 1.12 |
Fzd6 |
frizzled class receptor 6 |
171 |
0.67 |
chr1_185454772_185454950 | 1.12 |
Slc30a10 |
solute carrier family 30, member 10 |
13 |
0.93 |
chr1_182499377_182499701 | 1.12 |
Gm37069 |
predicted gene, 37069 |
5383 |
0.15 |
chr5_140701925_140702124 | 1.12 |
Iqce |
IQ motif containing E |
55 |
0.97 |
chr1_128359251_128359552 | 1.11 |
Mcm6 |
minichromosome maintenance complex component 6 |
246 |
0.91 |
chr4_130295556_130295719 | 1.11 |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
12958 |
0.13 |
chr2_168050390_168050551 | 1.11 |
Gm24327 |
predicted gene, 24327 |
14427 |
0.14 |
chr6_134983799_134984045 | 1.11 |
Apold1 |
apolipoprotein L domain containing 1 |
2204 |
0.23 |
chr10_70097931_70098284 | 1.11 |
Ccdc6 |
coiled-coil domain containing 6 |
986 |
0.66 |
chr6_39206583_39206759 | 1.10 |
Kdm7a |
lysine (K)-specific demethylase 7A |
118 |
0.8 |
chr13_46669712_46669863 | 1.10 |
Fam8a1 |
family with sequence similarity 8, member A1 |
265 |
0.9 |
chr7_143502466_143502878 | 1.10 |
Phlda2 |
pleckstrin homology like domain, family A, member 2 |
131 |
0.93 |
chr11_95824766_95825172 | 1.10 |
Phospho1 |
phosphatase, orphan 1 |
469 |
0.69 |
chr15_81693748_81693899 | 1.10 |
Chadl |
chondroadherin-like |
205 |
0.89 |
chr2_32681264_32681427 | 1.09 |
Fpgs |
folylpolyglutamyl synthetase |
3659 |
0.08 |
chr11_97415913_97416084 | 1.09 |
Arhgap23 |
Rho GTPase activating protein 23 |
465 |
0.78 |
chr5_52982752_52983050 | 1.09 |
Gm30301 |
predicted gene, 30301 |
864 |
0.54 |
chr1_156660314_156660660 | 1.09 |
Tor3a |
torsin family 3, member A |
2029 |
0.27 |
chr2_76406426_76406577 | 1.09 |
Osbpl6 |
oxysterol binding protein-like 6 |
7 |
0.98 |
chr19_47314026_47314308 | 1.09 |
Sh3pxd2a |
SH3 and PX domains 2A |
584 |
0.73 |
chr11_98741745_98741898 | 1.09 |
Thra |
thyroid hormone receptor alpha |
10 |
0.95 |
chr17_28692189_28692346 | 1.08 |
Mapk14 |
mitogen-activated protein kinase 14 |
301 |
0.83 |
chr2_104494283_104494434 | 1.08 |
Hipk3 |
homeodomain interacting protein kinase 3 |
88 |
0.97 |
chr1_182516753_182517327 | 1.08 |
Capn2 |
calpain 2 |
484 |
0.75 |
chr12_110889460_110889651 | 1.08 |
Tecpr2 |
tectonin beta-propeller repeat containing 2 |
243 |
0.61 |
chr13_60498026_60498203 | 1.08 |
A530001N23Rik |
RIKEN cDNA A530001N23 gene |
9306 |
0.17 |
chr7_3217705_3217856 | 1.08 |
Mir290a |
microRNA 290a |
846 |
0.18 |
chr17_30591215_30591503 | 1.08 |
Gm50244 |
predicted gene, 50244 |
149 |
0.92 |
chr1_39900650_39900910 | 1.07 |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
133 |
0.97 |
chr1_190121551_190121702 | 1.07 |
Gm28172 |
predicted gene 28172 |
47044 |
0.13 |
chr16_55974291_55974442 | 1.07 |
Zbtb11os1 |
zinc finger and BTB domain containing 11, opposite strand 1 |
251 |
0.66 |
chr5_105519125_105519276 | 1.07 |
Lrrc8c |
leucine rich repeat containing 8 family, member C |
188 |
0.95 |
chr8_106893571_106893752 | 1.06 |
Utp4 |
UTP4 small subunit processome component |
10 |
0.37 |
chr5_52979827_52979978 | 1.06 |
Gm30301 |
predicted gene, 30301 |
2135 |
0.25 |
chr17_56510493_56510644 | 1.06 |
Znrf4 |
zinc and ring finger 4 |
1863 |
0.26 |
chr6_47767852_47768003 | 1.05 |
Rpl31-ps7 |
ribosomal protein L31, pseudogene 7 |
18447 |
0.13 |
chr12_109987030_109987181 | 1.05 |
Gm34667 |
predicted gene, 34667 |
36768 |
0.09 |
chr9_65309566_65309762 | 1.05 |
Clpx |
caseinolytic mitochondrial matrix peptidase chaperone subunit |
488 |
0.65 |
chr2_104849084_104849595 | 1.05 |
Prrg4 |
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) |
154 |
0.94 |
chr13_93634275_93634633 | 1.05 |
Bhmt |
betaine-homocysteine methyltransferase |
3112 |
0.2 |
chr14_79480770_79480933 | 1.05 |
Wbp4 |
WW domain binding protein 4 |
111 |
0.77 |
chr19_46147867_46148242 | 1.05 |
Pitx3 |
paired-like homeodomain transcription factor 3 |
272 |
0.86 |
chr3_94363549_94363843 | 1.05 |
C2cd4d |
C2 calcium-dependent domain containing 4D |
1193 |
0.22 |
chr6_47753116_47753267 | 1.05 |
Rpl31-ps7 |
ribosomal protein L31, pseudogene 7 |
33183 |
0.12 |
chr15_100633353_100633521 | 1.05 |
Smagp |
small cell adhesion glycoprotein |
2063 |
0.15 |
chr6_47744422_47744573 | 1.04 |
Rpl31-ps7 |
ribosomal protein L31, pseudogene 7 |
41877 |
0.11 |
chr16_78376213_78376364 | 1.04 |
Btg3 |
BTG anti-proliferation factor 3 |
522 |
0.76 |
chr1_43934171_43934331 | 1.04 |
Tpp2 |
tripeptidyl peptidase II |
206 |
0.91 |
chr6_47748782_47748933 | 1.04 |
Rpl31-ps7 |
ribosomal protein L31, pseudogene 7 |
37517 |
0.11 |
chr2_150749210_150749398 | 1.04 |
Entpd6 |
ectonucleoside triphosphate diphosphohydrolase 6 |
133 |
0.94 |
chr8_122550942_122551215 | 1.04 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
251 |
0.84 |
chr6_47763548_47763699 | 1.03 |
Rpl31-ps7 |
ribosomal protein L31, pseudogene 7 |
22751 |
0.13 |
chr2_103849595_103849746 | 1.03 |
Gm13879 |
predicted gene 13879 |
6014 |
0.09 |
chr2_165034366_165034665 | 1.03 |
Ncoa5 |
nuclear receptor coactivator 5 |
272 |
0.89 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.9 | 3.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.9 | 2.7 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.9 | 2.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.8 | 2.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.8 | 5.6 | GO:0051775 | response to redox state(GO:0051775) |
0.8 | 3.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.7 | 2.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.7 | 2.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 3.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.6 | 1.9 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 2.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.6 | 1.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.6 | 1.8 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.6 | 1.7 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.6 | 1.7 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 2.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 2.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.5 | 1.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.5 | 2.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.5 | 1.6 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.5 | 1.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.5 | 3.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 2.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.5 | 1.6 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.5 | 2.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.5 | 1.5 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 1.5 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.5 | 3.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 3.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 1.4 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.5 | 1.4 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.5 | 1.9 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.5 | 1.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 1.4 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.5 | 1.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.4 | 1.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.4 | 1.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 1.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.4 | 1.8 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.4 | 2.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 1.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 1.7 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.4 | 2.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 1.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.4 | 1.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 1.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 1.6 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 1.2 | GO:0008050 | female courtship behavior(GO:0008050) |
0.4 | 1.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.4 | 0.8 | GO:0044838 | cell quiescence(GO:0044838) |
0.4 | 1.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 1.2 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.4 | 1.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 1.1 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 1.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 0.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.4 | 0.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 1.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.4 | 0.7 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 2.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 1.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.4 | 0.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 1.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 1.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.4 | 1.1 | GO:1900212 | pronephros development(GO:0048793) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
0.4 | 1.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.4 | 2.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 1.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 0.7 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 1.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 0.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 1.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.3 | 1.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.3 | 1.0 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 1.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 0.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 0.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 1.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 2.2 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 1.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 0.6 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.3 | 0.9 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 0.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 0.9 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.3 | 1.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 0.9 | GO:0048382 | mesendoderm development(GO:0048382) |
0.3 | 0.6 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 0.6 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.3 | 1.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 1.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.3 | 0.9 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.3 | 2.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.3 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 1.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.3 | 1.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.3 | 0.9 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 0.9 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.3 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 1.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.3 | 0.9 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 0.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 1.1 | GO:0035482 | gastric motility(GO:0035482) |
0.3 | 1.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.3 | 0.3 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.3 | 0.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.3 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.3 | 0.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 1.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.3 | 0.8 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.3 | 0.8 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.3 | 0.8 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 1.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 0.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 0.8 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.3 | 1.7 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.3 | 1.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 1.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 0.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 0.3 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.3 | 0.5 | GO:0045472 | response to ether(GO:0045472) |
0.3 | 0.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.3 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 1.4 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 2.7 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 0.8 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.3 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 2.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.3 | 1.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 1.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.3 | 1.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 0.8 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.3 | 2.3 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.3 | 0.8 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.3 | 1.0 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 3.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.3 | 2.6 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.3 | 1.5 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 1.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 0.5 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 0.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 1.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.3 | 0.5 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.3 | 0.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 | 1.3 | GO:0032329 | serine transport(GO:0032329) |
0.3 | 0.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 2.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.5 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.2 | 1.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.2 | 0.7 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.2 | 1.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.2 | 1.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 1.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.5 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.2 | 1.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 0.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.2 | 0.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 1.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 1.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.2 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.2 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.2 | 0.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 0.9 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.2 | 0.2 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.2 | 0.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 1.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 2.0 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 1.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.7 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 0.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 1.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.2 | 1.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.2 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.2 | 1.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 0.4 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.2 | GO:0010665 | regulation of cardiac muscle cell apoptotic process(GO:0010665) |
0.2 | 0.6 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.2 | 0.4 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.2 | 0.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.2 | 0.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.6 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 1.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 0.6 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.2 | 0.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.6 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.6 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.2 | 1.7 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 0.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 0.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 0.4 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.2 | 1.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 1.3 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.2 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.2 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.2 | 0.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 2.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.6 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.2 | 0.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.4 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.2 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 1.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 1.4 | GO:0035878 | nail development(GO:0035878) |
0.2 | 1.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.6 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.2 | 0.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 2.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 1.0 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 1.0 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.6 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.2 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 2.3 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.2 | 0.8 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.4 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 0.6 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 0.4 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.2 | 0.2 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 0.6 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 1.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 1.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 1.3 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 0.6 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.8 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 0.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.6 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.6 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.6 | GO:0046137 | negative regulation of vitamin metabolic process(GO:0046137) |
0.2 | 1.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 1.1 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.2 | 0.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 3.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 0.2 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 1.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.5 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 1.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 0.5 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 4.5 | GO:0030901 | midbrain development(GO:0030901) |
0.2 | 0.9 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 0.5 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 0.7 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.2 | 1.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 1.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.5 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 2.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 1.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.5 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.2 | 0.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.5 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.4 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 0.9 | GO:2000301 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 1.2 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.2 | 1.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.7 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.7 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 1.0 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 1.0 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 0.7 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.3 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.2 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 1.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 0.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 1.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 1.5 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.2 | 0.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 1.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 0.7 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.2 | 1.3 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.8 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.2 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.2 | 0.6 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.2 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.5 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.6 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 1.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.2 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.2 | 0.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 2.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 1.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.2 | 0.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.4 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.6 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.3 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 2.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.1 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 1.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.7 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 1.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.6 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.7 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 2.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 1.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 1.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 1.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.7 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.9 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 1.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 2.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 1.0 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.4 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 1.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 1.0 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.6 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.3 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.1 | 0.3 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.1 | 0.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.8 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.1 | 1.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.7 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.7 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 0.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 2.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.1 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.1 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.4 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.1 | 0.9 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 1.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.4 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.1 | 0.4 | GO:0072497 | mesenchymal stem cell differentiation(GO:0072497) |
0.1 | 0.8 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.6 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.6 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 1.3 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 1.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 1.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.6 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.3 | GO:0006901 | vesicle coating(GO:0006901) |
0.1 | 1.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 1.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.5 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.5 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 1.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.4 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.4 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 1.2 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.1 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.1 | 0.4 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.2 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 1.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 1.0 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 1.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.7 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.4 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 0.4 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.1 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.3 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.6 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 2.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 2.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.8 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.2 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.1 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.3 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.1 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.1 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.2 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.1 | 0.3 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.8 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.6 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 0.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 1.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.7 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.4 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 1.9 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 1.3 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.4 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.2 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.1 | 0.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 2.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.3 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 2.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 1.3 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.1 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.1 | 0.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.5 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 2.0 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.5 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.3 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.4 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 1.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.5 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.2 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 1.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 1.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.1 | 0.2 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.1 | GO:0051231 | spindle elongation(GO:0051231) |
0.1 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.6 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 1.5 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.1 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.1 | 0.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0051645 | Golgi localization(GO:0051645) |
0.1 | 1.2 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.1 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.4 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.1 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 3.6 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.2 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.1 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.6 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.3 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.1 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.4 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.3 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.3 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 1.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 0.6 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 1.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 3.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.4 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 1.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.3 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.7 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 1.5 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 0.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.5 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.1 | 0.1 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.1 | GO:0002719 | negative regulation of cytokine production involved in immune response(GO:0002719) |
0.1 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.1 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.8 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.1 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.1 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 1.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 1.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.1 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.1 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.1 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.1 | 0.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.1 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.8 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.1 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.1 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.5 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.6 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.1 | 1.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 1.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.9 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.5 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.2 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.5 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 1.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.4 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) |
0.1 | 0.5 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.6 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.9 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.1 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
0.1 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.2 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.1 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.1 | 0.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 0.3 | GO:0008334 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) histone mRNA metabolic process(GO:0008334) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 1.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.2 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 1.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 1.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.5 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 1.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.8 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.2 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.5 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.5 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 0.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.3 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.1 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.6 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.6 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.3 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.1 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.2 | GO:0006560 | proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.3 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.4 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.7 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 1.0 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.1 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.4 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.1 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.5 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.3 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.3 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 1.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.2 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.5 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.3 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.0 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.3 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.3 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.0 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.3 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.6 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.2 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.0 | 0.4 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 3.6 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.0 | 0.0 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.3 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.4 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.1 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.3 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.1 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.0 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.0 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.0 | 0.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.0 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.4 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.5 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.0 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.3 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.0 | 0.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.2 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 0.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
0.0 | 0.2 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.0 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.0 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.2 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.0 | 0.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 1.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.7 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 1.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.0 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.0 | 0.1 | GO:0014856 | skeletal muscle cell proliferation(GO:0014856) |
0.0 | 0.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.6 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.0 | 0.4 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.5 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.0 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.2 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.8 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.2 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.1 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
0.0 | 0.0 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.0 | 0.1 | GO:0051187 | cofactor catabolic process(GO:0051187) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.2 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.1 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.0 | 0.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.2 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.0 | 0.0 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.0 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.0 | 0.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.0 | 0.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.1 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.5 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.2 | GO:0043489 | RNA stabilization(GO:0043489) |
0.0 | 0.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.0 | 0.0 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.0 | GO:0015677 | copper ion import(GO:0015677) |
0.0 | 0.0 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.3 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.0 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.0 | 0.3 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.0 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0060430 | lung saccule development(GO:0060430) |
0.0 | 0.0 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.0 | 0.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 1.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.0 | 1.0 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.5 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.3 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.0 | 0.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.0 | 0.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.0 | 0.1 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0086068 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.0 | 0.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.0 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.7 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.3 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
0.0 | 0.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.0 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.0 | 0.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.1 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0015810 | aspartate transport(GO:0015810) |
0.0 | 0.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.0 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.1 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.0 | 0.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.0 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.0 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.0 | 0.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.6 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.0 | 0.0 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.0 | 0.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.0 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.2 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.0 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) |
0.0 | 0.2 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 1.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.0 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.0 | 0.0 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.4 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.0 | GO:0036314 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.0 | 0.0 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.0 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.0 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.0 | 0.0 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.3 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.0 | GO:0098534 | centriole assembly(GO:0098534) |
0.0 | 0.0 | GO:0061743 | motor learning(GO:0061743) maintenance of synapse structure(GO:0099558) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.0 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 | 0.1 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.7 | 2.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 2.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 1.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.5 | 0.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.5 | 2.4 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 1.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 1.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.4 | 1.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 1.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 2.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 4.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 1.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 1.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 2.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 2.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 2.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 1.0 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 2.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 0.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 0.6 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 0.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 0.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 0.9 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 1.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 2.2 | GO:0005903 | brush border(GO:0005903) |
0.3 | 2.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 1.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 0.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.7 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 1.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 1.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 1.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.7 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.5 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 1.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 2.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 3.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 1.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.2 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.6 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 3.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 1.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 0.8 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 0.6 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.2 | 1.1 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 2.4 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.7 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 3.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.9 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.2 | 0.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 2.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 0.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 0.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 1.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 1.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 2.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 6.8 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 0.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.9 | GO:0005818 | aster(GO:0005818) |
0.1 | 0.3 | GO:0030894 | replisome(GO:0030894) |
0.1 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.9 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 1.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 1.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.3 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 1.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.4 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 1.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.8 | GO:0098576 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 2.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 1.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 1.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 2.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 1.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 1.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.5 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.4 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 1.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 1.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 3.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 5.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.8 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 3.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 4.4 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 1.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 2.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 1.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 2.8 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 1.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 1.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 5.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 4.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.1 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 3.1 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 2.0 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 1.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:0090533 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 4.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 1.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.1 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 3.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 2.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 2.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.9 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.1 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 1.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 2.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 2.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.7 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.9 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 1.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.6 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.9 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 1.8 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 4.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 15.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 4.8 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 1.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 1.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 4.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.0 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.0 | 0.6 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.1 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.4 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 4.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 1.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 1.1 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.3 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 2.7 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 1.5 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 1.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 1.3 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 1.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 3.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.6 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 1.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.3 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.5 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 0.8 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 2.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.3 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 1.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 1.5 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.8 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.0 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.0 | GO:0031090 | organelle membrane(GO:0031090) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 3.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 4.2 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 5.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 2.2 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 6.1 | GO:0030054 | cell junction(GO:0030054) |
0.0 | 3.1 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.3 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 7.3 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.6 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 4.5 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 3.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 2.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.0 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 23.9 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 1.3 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 1.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 16.2 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.5 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 3.1 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.3 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 2.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.3 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.1 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 23.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 10.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 15.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 11.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 38.6 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 35.4 | GO:0016021 | integral component of membrane(GO:0016021) intrinsic component of membrane(GO:0031224) |
0.0 | 1.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.0 | GO:0036126 | sperm flagellum(GO:0036126) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 1.8 | GO:1990188 | euchromatin binding(GO:1990188) |
0.6 | 0.6 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.5 | 1.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 3.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 1.5 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.5 | 3.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 1.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 1.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 1.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 4.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 1.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 1.2 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 2.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.4 | 1.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 1.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 1.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 0.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.4 | 1.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 1.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 2.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.3 | 1.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 1.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 1.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 1.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 2.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 1.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 0.9 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.3 | 0.9 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 0.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.3 | 0.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 0.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 0.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 2.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 0.9 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 1.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 0.8 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 0.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 0.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 0.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 3.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 0.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 1.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 0.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 0.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 1.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 2.3 | GO:0070251 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 3.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 1.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 7.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 3.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 1.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 0.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 1.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 2.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 1.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.5 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 2.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 1.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 1.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 2.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 1.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 3.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.2 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.2 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 2.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 1.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 5.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 1.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 0.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 3.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 1.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.3 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.4 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 0.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.2 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 3.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.9 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 0.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 4.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 1.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 1.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.6 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 1.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 1.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 1.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 1.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 2.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 4.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 1.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 1.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.7 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 2.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.7 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 1.4 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 1.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 4.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 3.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 1.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.9 | GO:0018639 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 3.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.5 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 1.4 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.5 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.5 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.5 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 2.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 1.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 1.0 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 3.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 1.0 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 1.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 1.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 9.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.7 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 1.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 2.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 1.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 3.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 2.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 3.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 1.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 3.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.5 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.1 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.8 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 8.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 2.9 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.9 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 3.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 3.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 3.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 1.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.7 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 3.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 2.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.0 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.1 | 12.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 2.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.6 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 1.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 2.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.0 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 2.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.7 | GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.1 | 4.8 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.7 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.1 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.3 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.4 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 1.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 3.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 1.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.4 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 1.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 2.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 7.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 5.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.5 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 2.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.4 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.8 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 2.2 | GO:0070738 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.0 | 1.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 7.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 6.7 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 4.5 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.0 | 0.0 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 1.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0001226 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.8 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 2.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 2.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 1.7 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 1.0 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.1 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 2.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 7.1 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.2 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 5.5 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.5 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 1.7 | GO:0042277 | peptide binding(GO:0042277) |
0.0 | 0.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 11.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.8 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.9 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.8 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.0 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0034891 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.6 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.8 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.2 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.7 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.0 | 0.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 1.0 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.4 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 2.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 4.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 4.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 6.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 1.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 9.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 6.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 1.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 4.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 4.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 3.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 2.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 2.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 3.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 3.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 4.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 2.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 2.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 1.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 8.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 3.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 3.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 4.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 2.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 1.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 3.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 0.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 2.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 1.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 1.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 3.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.2 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 4.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 1.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 1.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 1.2 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.2 | 1.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 3.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 4.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 3.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 1.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 0.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 2.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 2.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 0.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 2.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.2 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 1.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.5 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 2.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 3.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 4.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 2.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 3.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.5 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 2.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 2.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 4.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 2.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 4.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 1.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 11.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.8 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.2 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.1 | 1.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.0 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 1.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 4.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 0.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 3.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 1.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 1.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 1.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.3 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 4.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 1.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.3 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.0 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.0 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.4 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |